Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder.
Bartova L, Fugger G, Dold M, Kautzky A, Fanelli G, Zanardi R, Albani D, Weidenauer A, Rujescu D, Souery D, Mendlewicz J, Montgomery S, Zohar J, Fabbri C, Serretti A, Kasper S.
Bartova L, et al. Among authors: kautzky a.
J Affect Disord. 2023 Jul 1;332:105-114. doi: 10.1016/j.jad.2023.03.068. Epub 2023 Mar 22.
J Affect Disord. 2023.
PMID: 36958488
Free article.